Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patients

Diabetic Medicine

Volumn 23, Issue 8, 2006, Pages 894-899

  Watarai, A ^a   Nakashima, E ^a,b   Hamada, Y ^a   Watanabe, G ^a   Naruse, K ^a   Miwa, K ^a   Kobayashi, Y ^a   Kamiya, H ^a   Nakae, M ^a   Hamajima, N ^b   Sekido, Y ^a   Niwa, T ^a   Oiso, Y ^a   Nakamura, J ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Aldose reductase; Atherosclerosis; Macroangiopathy; Polymorphism; Stroke

Indexed keywords

ALDEHYDE REDUCTASE; CHOLESTEROL; CREATININE; HEMOGLOBIN A1C; POLYOL; TRIACYLGLYCEROL;

ADULT; AGED; ALLELE; ARTICLE; ASIAN; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC ANGIOPATHY; DIABETIC PATIENT; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE LEVEL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION; PROTEIN CONTENT; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ALDEHYDE REDUCTASE; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 33746580371     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2006.01946.x     Document Type: Article

References (28)

1. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 438-443.
2. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev 1998; 50: 21-33.
3. Chung SS, Chung SK. Genetic analysis of aldose reductase in diabetic complications. Current Med Chem 2003; 10: 1375-1387.
4. Demaine AG. Polymorphisms of the aldose reductase gene and susceptibility to diabetic microvascular complications. Current Med Chem 2003; 10: 1389-1398.
5. Kao YL, Donaghue K, Chan A, Knight J, Silink M. A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes 1999; 48: 1338-1340.
6. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich CC, Warram JH et al. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus. Diabet Med 2000; 17: 111-118.
7. Neamat-Allah M, Feeney SA, Savage DA, Maxwell AP, Hanson RL, Knowler WC et al. Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus. Diabet Med 2001; 18: 906-914.
8. Wang Y, Ng MC, Lee SC, So WY, Tong PC, Cockram CS et al. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care 2003; 26: 2410-2415.
9. Makiishi T, Araki S, Koya D, Maeda S, Kashiwagi A, Haneda M. C-106T polymorphism of AKR1B1 is associated with diabetic nephropathy and erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes mellitus. Am J Kidney Dis 2003; 42: 943-951.
10. Sivenius K, Niskanen L, Voutilainen-Kaunisto R, Laakso M, Uusitupa M. Aldose reductase gene polymorphisms and susceptibility to microvascular complications in Type 2 diabetes. Diabet Med 2004; 21: 1325-1333.
11. Sivenius K, Pihlajamäki J, Partanen J, Niskanen L, Laakso M, Uusitupa M. Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes. Diabetes Care 2004; 27: 2021-2026.
12. Gosek K, Moczulski D, Zukowska-Szczechowska E, Grzeszczak W. C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control. Nephron Exp Nephrol 2005; 99: E63-E67.
13. Kasuya Y, Ito M, Nakamura J, Hamada Y, Nakayama M, Chaya S et al. An aldose redutase inhibitor prevents the intimal thickening in coronary arteries of galactose-fed beagle dogs. Diabetologia 1999; 42: 1404-1409.
14. Ramana KV, Chandra D, Srivastava S, Bhatnagar A, Aggarwal BB, Srivastava SK. Aldose reductase mediates mitogenic signaling in vascular smooth muscle cells. J Biol Chem 2002; 277: 32063-32070.
15. Nakamura J, Kasuya Y, Hamada Y, Nakashima E, Naruse K, Yasuda Y et al. Glucose-induced hyperproliferation of cultured rat aortic smooth muscle cells through polyol pathway hyperactivity. Diabetologia 2001; 44: 480-487.
16. Li W, Hamada Y, Nakashima E, Naruse K, Kamiya H, Akiyama N et al. Suppression of 3-deoxyglucosone and heparin-binding epidermal growth factor-like growth factor mRNA expression by an aldose reductase inhibitor in rat vascular smooth muscle cells. Biochem Biophys Res Commun 2004; 314: 370-376.
17. Adams HP, Woolson RF, Biller J, Clarke W. Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group. Haemostasis 1992; 22: 99-103.
18. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809.
19. Yasunari K, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol 1995; 15: 2207-2212.
20. Kasuya Y, Nakamura J, Hamada Y, Nakayama M, Sasaki H, Komori T et al. An aldose reductase inhibitor prevents the glucose-induced increase in PDGF-β receptor in cultured rat aortic smooth muscle cells. Biochem Biophys Res Commun 1999; 261: 853-858.
21. Ramana KV, Friedrich B, Srivastava S, Bhatnagar A, Srivastava SK. Activation of nuclear factor-κB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 2004; 53: 2910-2920.
22. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG. The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy. Diabetes 2003; 52: 846-851.
23. Yang B, Millward A, Demaine A. Functional differences between the susceptibility Z-2/C-106 and protective Z+2/T-106 promoter region polymorphisms of the aldose reductase gene may account for the association with diabetic microvascular complications. Biochim Biophys Acta 2003; 1639: 1-7.
24. Pezzini A, Grassi M, Del Zotto E, Archetti S, Spezi R, Vergani V et al. Cumulative effect of predisposing genotypes and their interaction with modifiable factors on the risk of ischemic stroke in young adults. Stroke 2005; 36: 533-539.
25. Henry DN, Del Monte M. Greene DA. Killen PD. Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J Clin Invest 1993; 92: 617-623.
26. Ko BC, Ruepp B, Bohren KM, Gabbay KH, Chung SS. Identification and characterization of multiple osmotic response sequences in the human aldose reductase gene. J Biol Chem 1997; 272: 16431-16437.
27. Ruepp B, Bohren KM, Gabbay KH. Characterization of the osmotic response element of the human aldose reductase gene promoter. Proc Natl Acad Sci USA 1996; 93: 8624-8629.
28. Spycher SE, Tabataba-Vakili S, O'Donnell VB, Palomba L, Azzi A. Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J 1997; 11: 181-188.